Unmasking a killer:: DNA O6-methylguanine and the cytotoxicity of methylating agents

被引:161
作者
Bignami, M
O'Driscoll, M
Aquilina, G
Karran, P
机构
[1] Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England
[2] Ist Super Sanita, I-00161 Rome, Italy
关键词
O-6-methylguanine; cytotoxicity; mismatch repair; mutation induction;
D O I
10.1016/S1383-5742(00)00016-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Methylating agents are potent carcinogens that are mutagenic and cytotoxic towards bacteria and mammalian cells. Their effects can be ascribed to an ability to modify DNA covalently, Pioneering studies of the chemical reactivity of methylating agents towards DNA components and their effectiveness as animal carcinogens identified O-6-methylguanine (O(6)meG) as a potentially important DNA lesion. Subsequent analysis of the effects of methylating carcinogens in bacteria and cultured mammalian cells - including the discovery of the inducible adaptive response to alkylating agents in Escherichia coli have defined the contributions of O(6)meG and other methylated DNA bases to the biological effects of these chemicals. More recently, the role of O(6)meG in killing mammalian cells has been revealed by the lethal interaction between persistent DNA O(6)meG and the mismatch repair pathway. Here, we briefly review the results which led to the identification of the biological consequences of persistent DNA O(6)meG. We consider the possible consequences for a human cell of chronic exposure to low levels of a methylating agent. Such exposure may increase the probability that the cell's mismatch repair pathway becomes inactive. Loss of mismatch repair predisposes the cell to mutation induction, not only through uncorrected replication errors but also by methylating agents and other mutagens. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:71 / 82
页数:12
相关论文
共 63 条
[21]   Cellular resistance and hypermutability in mismatch repair-deficient human cancer cell lines following treatment with methyl methanesulfonate [J].
Glaab, WE ;
Risinger, JI ;
Umar, A ;
Barrett, JC ;
Kunkel, TA ;
Tindall, KR .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 398 (1-2) :197-207
[22]   Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus [J].
Glaab, WE ;
Risinger, JI ;
Umar, A ;
Barrett, JC ;
Kunkel, TA ;
Tindall, KR .
CARCINOGENESIS, 1998, 19 (11) :1931-1937
[23]   INDUCED MUTAGENESIS IN DAM[-]MUTANTS OF ESCHERICHIA-COLI - ROLE FOR 6-METHYLADENINE RESIDUES IN MUTATION AVOIDANCE [J].
GLICKMAN, B ;
VANDENELSEN, P ;
RADMAN, M .
MOLECULAR AND GENERAL GENETICS, 1978, 163 (03) :307-312
[24]   PERSISTENCE OF O6-ETHYLGUANINE IN RAT-BRAIN DNA - CORRELATION WITH NERVOUS SYSTEM-SPECIFIC CARCINOGENESIS BY ETHYLNITROSOUREA [J].
GOTH, R ;
RAJEWSKY, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (03) :639-643
[25]  
HARRIS AL, 1983, CANCER RES, V43, P3247
[26]   EXPRESSION AND CLONING OF COMPLEMENTARY-DNA FOR A HUMAN ENZYME THAT REPAIRS O-6-METHYLGUANINE IN DNA [J].
HAYAKAWA, H ;
KOIKE, G ;
SEKIGUCHI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 213 (04) :739-747
[27]   Mismatch repair and differential sensitivity of mouse and human cells to methylating agents [J].
Humbert, O ;
Fiumicino, S ;
Aquilina, G ;
Branch, P ;
Oda, S ;
Zijno, A ;
Karran, P ;
Bignami, M .
CARCINOGENESIS, 1999, 20 (02) :205-214
[28]  
Kane MF, 1997, CANCER RES, V57, P808
[29]   ESCHERICHIA-COLI MUTANTS DEFICIENT IN 3-METHYLADENINE-DNA GLYCOSYLASE [J].
KARRAN, P ;
LINDAHL, T ;
OFSTENG, I ;
EVENSEN, GB ;
SEEBERG, E .
JOURNAL OF MOLECULAR BIOLOGY, 1980, 140 (01) :101-127
[30]   SELF-DESTRUCTION AND TOLERANCE IN RESISTANCE OF MAMMALIAN-CELLS TO ALKYLATION DAMAGE [J].
KARRAN, P ;
BIGNAMI, M .
NUCLEIC ACIDS RESEARCH, 1992, 20 (12) :2933-2940